cas 202062-80-4|| where to buy 4-(1,3-dioxolan-2-yl)piperidine

Nombre del producto:4-(1,3-dioxolan-2-yl)piperidine

IUPAC Name:4-(1,3-dioxolan-2-yl)piperidine

Unidad de embalaje	Stock disponible	Precio($)
CM743777-1g	in stock	ůĲ
CM743777-5g	in stock	ĲƥŹ
CM743777-10g	in stock	ůƿȃ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 202062-80-4 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :202062-80-4; Fórmula molecular:C8H15NO2; Punto de fusión:-; Código de sonrisas:C1COC(O1)C1CCNCC1; Densidad:

: Número de catálogo:CM743777; Peso molecular:157.21; Punto de ebullición:; Nº Mdl:MFCD16547635; Almacenamiento:

: Piperidines; Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.; Piperidine,Piperidine Price; if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.

: Dioxolanes; Dioxolane is a heterocyclic acetal with the formula (CH2)2O2CH2. It is related to tetrahydrofuran by exchanging an oxygen for the CH2 group. The isomer 1,2-dioxolane (in which the two oxygen centers are adjacent) is a peroxide. 1,3-Dioxolane is used as solvent and comonomer in polyacetal. The dioxolane-type and their hydrogenolysis can provide very valuable partially protected building blocks either for oligosaccharide syntheses or sugar transformations.

: NX-5948; Nurix announced the presentation of the first findings of clinical responses in the brain for NX-5948. NX-5948 is an investigational, orally bioavailable, brain penetrant, small molecule degrader of BTK. NX-5948 is currently being evaluated in a Phase 1 clinical trial in patients with relapsed or refractory B cell malignancies.